eli lilly glp-1 advantage decreasing The battle over the trillion-dollar weight-loss bonanza A Big Week for GLP-1

Its once-weekly injection format adds convenience, while its expanding research into cardiovascular and obesity-related benefits points toward even broader uses in the future

GLP-1 Treatment Readiness Assessment for Adults Medications such as Ozempic, Mounjaro, and Zepbound have helped many people achieve meaningful weight loss by reducing appetite and improving metabolic regulation

doi:10.1056/NEJMoa2501006

Our study did not evaluate cost-effectiveness

has been a speaker and scientific consultant for Novo Nordisk

For more information about the history and design of the American Life Panel, see Pollard and Baird (2017)